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Background
According to the Centers for Disease Control and Prevention, prostate cancer is the most 
common form of cancer and the second leading cause of cancer deaths among men in the 
United States. Increased consumption of isoflavones, organic compounds found primarily 
in soy, may be associated with a reduced risk for prostate cancer. However, the mechanisms 
by which soy isoflavones reduce cancer risk are not well characterized. Understanding 
these anticancer mechanisms is an important step in the development of dietary 
recommendations to reduce cancer risk and may also lead to the development of new food 
products with increased health benefits. This project was awarded a SEEDS grant to further 
research on soy use as a possible measure for reducing prostate cancer risk.
 
Objectives
The overall goal of this study was to examine the ability of glycitein, an isoflavone found 
in soy, to modulate cellular and molecular processes associated with prostate cancer 
development. Two primary objectives were proposed. The first objective aimed to 
characterize the involvement of the vascular endothelial growth factor (VEGF) receptor 
in mediating effects of glycitein on signaling pathways associated with growth of prostate 
epithelial cells. The second research objective was to examine the influence of glycitein on 
proliferation and differentiation of prostate epithelial cells. 
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Impacts
To date, scientists have further elucidated the role of the VEGF receptor in mediating 
glycitein’s effect on cellular signaling in the prostate. This work has identified a novel 
mechanism by which soy isoflavones exert their anticancer activity in the prostate. 
These findings were recently published in The Journal of Nutritional Biochemistry.
In addition, researchers have data suggesting that glycitein can influence prostate 
cell differentiation. Scientists believe that the ability of glycitein to influence cellular 
differentiation in the prostate may reduce the loss of critical cells in this tissue during 
the cancer process. A manuscript detailing these findings has recently been accepted 
for publication in Nutrition and Cancer: An International Journal. Collaborations are 
already in the works to further this research, as its potential impacts could be greatly 
beneficial for combating prostate cancer. 
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